Summary:
Click image to enlargeA Randomized, Double-Blind, Placebo-Controlled Trial of Adjunctive Troriluzole for Obsessive-Compulsive Disorder
Key Points:
- Subjects can roll over into an extension study.
Qualified Participants Must:
• Male and female outpatient subjects between the ages of 18-65
•
Subjects must be currently experiencing non-response or inadequate response to their current medication
Qualified Participants May Receive:
If qualify and decide to participate compensation is $100 after each completed appointment